In suspected airway obstruction, the first steps focus on opening and keeping the airway clear with simple, noninvasive maneuvers. The head tilt–chin lift is used to lift the tongue away from the back of the throat and align the passages so air can flow more easily, a straightforward move when there’s no concern about neck injury. The jaw thrust also opens the airway by moving the mandible forward, and it’s particularly important when spinal injury might be present because it avoids extending the neck. An airway adjunct, like an oropharyngeal or nasopharyngeal airway, helps keep the throat from collapsing and maintains patency once the airway is opened. Laryngoscopy is different. It’s an invasive procedure that visualizes the larynx to guide placement of a definitive airway, such as an endotracheal tube. It’s not one of the initial opening techniques you’d use to rapidly improve airway patency in a suspected obstruction; it’s a subsequent step when basic maneuvers fail or a definitive airway is being secured.

The main idea is that this trio of medications is a classic foundation for treating heart failure. Each drug class tackles a different part of the problem: ACE inhibitors block the renin-angiotensin-aldosterone system, which lowers afterload and helps prevent harmful remodeling of the heart; diuretics reduce fluid overload, easing preload and edema; beta blockers blunt excessive sympathetic stimulation, which over time improves heart function and survival in chronic heart failure. This combination is especially typical when heart failure stems from coronary heart disease, where ischemic damage leads to reduced pumping ability and fluid buildup. While these drugs can be used in hypertension, they’re not the standard trio for asthma or diabetes, making heart failure the best fit for this prescription pattern.

During resuscitation for pulseless VT/VF, the priority after the second defibrillation is to add an antiarrhythmic to stop the ongoing chaotic electrical activity and improve the chance of return of spontaneous circulation. Amiodarone is the preferred choice because it has broad antiarrhythmic effects, blocking multiple channels and prolonging refractoriness, which helps terminate persistent VT/VF and stabilizes the rhythm during ongoing CPR. This makes it more effective in this situation than other options. If amiodarone isn’t available, lidocaine is a backup antiarrhythmic, but it’s not the first choice. Magnesium is reserved for torsades de pointes or low magnesium states, and epinephrine is used to improve perfusion during CPR but does not directly terminate refractory VT/VF.

When the airway is obstructed and you can’t intubate, needle cricothyrotomy serves as a rapid bridge to ventilation by delivering oxygen directly through a needle or small cannula placed through the cricothyroid membrane into the trachea. This approach bypasses the obstruction and can provide effective oxygenation in the moment, which is crucial to save a patient who cannot be ventilated by other means. However, its ventilation capability is limited because the small bore and temporary nature mean CO2 clearance and overall ventilation may be insufficient for longer periods. The method also carries risks such as pneumothorax and subcutaneous emphysema if air escapes into the tissues or pleural space. Because of these limitations, it is intended as a temporary measure until a definitive airway—typically a surgical cricothyrotomy or formal tracheostomy—can be established. The other statements aren’t accurate in this context: surgical cricothyrotomy provides a definitive airway but is a different procedure with its own risks and isn’t described as being “less frequent” in the sense implied; needle cricothyrotomy is not the preferred method for all trauma scenarios; and it can indeed be used when there is airway obstruction.